A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome

ConclusionOur results suggest that intranasal oxytocin is not efficacious in improving the core symptoms of ASD in children with PMS.Trial registration NCT02710084.
Source: Molecular Autism - Category: Molecular Biology Source Type: research